-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Vitro Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
- Vitro Biopharma, Inc. Operating Income (Loss) for the quarter ending July 31, 2024 was -$1.25M, a 20.7% decline year-over-year.
- Vitro Biopharma, Inc. Operating Income (Loss) for the twelve months ending July 31, 2024 was -$8.91M, a 49.8% decline year-over-year.
- Vitro Biopharma, Inc. annual Operating Income (Loss) for 2023 was -$5.38M, a 9.8% increase from 2022.
- Vitro Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$5.97M.
- Vitro Biopharma, Inc. annual Operating Income (Loss) for 2015 was -$158K, a 7.55% increase from 2014.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)